Consolidated Statements of Loss and Comprehensive Loss - USD ($) $ in Thousands |
12 Months Ended | ||
|---|---|---|---|
Dec. 31, 2021 |
Dec. 31, 2020 |
Dec. 31, 2019 |
|
| EXPENSES | |||
| Research and development | $ 23,966 | $ 6,882 | $ 9,674 |
| General and administrative | 9,128 | 7,868 | 6,854 |
| Total operating expenses | 33,094 | 14,750 | 16,528 |
| OTHER INCOME (EXPENSE) | |||
| Interest income | 17 | 69 | 170 |
| Other expenses | (75) | (49) | (37) |
| Total other income (expense) | (58) | 20 | 133 |
| Net loss and comprehensive loss | $ (33,152) | $ (14,730) | $ (16,395) |
| Basic and diluted net loss per common share [note 1 and note 12 [g]] | $ (4.08) | $ (5.42) | $ (39.76) |
| Shares used in computation of basic and diluted net loss per common share [note 1 and note 12 [g]] | 8,119,836 | 2,718,909 | 412,320 |